Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine Doses for Anxiety and Depression in Ectopic Pregnancy Surgery
NCT07009808Not yet recruiting
- Sponsor
- Chengdu Jinjiang Maternity and Child Health Hospital
- Start
- Jun 2025
- Primary completion
- Oct 2025
- Modality
- Orthosteric Ligands
01
Overview
Randomised trial of nalbuphine in postoperative pain, anxiety disorder and major depressive disorder (MDD) (3 arms), sponsored by Chengdu Jinjiang Maternity and Child Health Hospital. Primary endpoint: Postoperative Anxiety and Depression Scores. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
nalbuphine
03
Conditions
postoperative painanxiety disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07009808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07009808.